Immunogenomic determinants of response to immune checkpoint inhibition in ovarian cancer: Insights from the NRG-GY003 clinical trial

Gynecologic Oncology 2026

View at publisher
Authors: Kelsey R. Monson, Nezar Mehanna, Michael Sill, Zhihong Chen, Melih Ozsoy, Heather A. Lankes, Roisin O'Cearbhaill, Laura Holman, Premal Thaker, Cara Mathews, Sharad Ghamande, Amy J. Bregar
+6 more Robert DeBernardo, John Chan, Daniel Powell, Carol A Aghajanian, Robert Burger, Dmitriy Zamarin
DOI: 10.1016/j.ygyno.2026.02.031
Cited by: 1

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers PARP inhibition in cancer therapy Ferroptosis and cancer prognosis

Publication details

Journal / source
Gynecologic Oncology
Publisher
Elsevier BV
Volume
208
Pages
S457–S458
Publication date
23 April 2026
Language
EN